Lockheed Martin to enhance exoskeleton tech
Lockheed Martin has licensed B-Temia's bionic augmentation technology, Dermoskeleton, as it looks to enhance its exoskeleton solutions.
Dermoskeleton is the basis for computer-controlled devices that can increase mobility and load-carrying capacity by counteracting overstress on the lower back and legs. The technology offers a potential pathway to increase loadbearing and agility in Lockheed Martin's FORTIS industrial exoskeleton.
Lockheed Martin's technology license permits use of B-Temia technology to products for military, industrial, commercial and first-responder applications.
The FORTIS exoskeleton is an unpowered, lightweight exoskeleton that increases an operator's strength and endurance by transferring the weight of heavy loads from the operator's body directly to the ground through a series of joints at the hips, knees and ankles.
B-Temia's Dermoskeleton technology provides improved mobility, strength and autonomy to the user, with applications in the medical, industrial and military fields.
More from Military Logistics
New contract to support the Ardour turbofan is worth more than $1 billion.
A pair of A330s will be converted by Airbus for aerial refuelling, logistical support, humanitarian aid, and medical evacuations.
The latest $1.4 billion contract modification for General Dynamics NASSCO covers a new Expeditionary Sea Base ship and two more John Lewis-class fleet oilers.
New MRO contract between Boeing Defence Australia and RUAG Australia replaces work previously done in the US.
A systems integration contract for UK RN submarines is being extended to major surface vessels.
Austal USA is to build two additional Navajo-class towing, salvage and rescue ships for the USN, after Naval Sea Systems Command (NAVSEA) exercised a $156.17 …